Platelet-rich plasma (PRP) · Lesson 20 of 25 · 3 min

How strong is the clinical evidence for PRP?

PRP has a large research base, but study quality and preparation methods vary. This guide explains how the evidence is graded and where it is stronger or weaker.

Gloved hands placing a sample tube into a centrifuge

Key takeaways.

  • Knee osteoarthritis is the most studied PRP use, with 39 systematic reviews counted in one 2024 summary.
  • GRADE rates certainty of evidence from high to very low across five domains.
  • Evidence certainty is rated around moderate for knee osteoarthritis and diabetic foot ulcers.
  • Certainty is rated lower for tendinopathy, hair restoration and facial rejuvenation.
  • Variation in how PRP is prepared and reported is the main limit on the evidence.
  • A low GRADE rating signals uncertainty about the true effect. It is not proof of no effect.

A large but uneven research base

PRP has been studied in many trials and reviews. A 2024 summary found 39 systematic reviews and meta-analyses for knee osteoarthritis alone. Volume is not the same as certainty, because the studies use very different preparations and methods.

The regulatory position is separate from the research picture. PRP applications are considered off-label.

How GRADE rates the evidence

GRADE is a widely used system for rating how certain a body of evidence is. Ratings run from high to very low. Randomized trials start as high and observational studies start as low.

Evidence is then judged on five domains: risk of bias, inconsistency, indirectness, imprecision and publication bias. Problems in any domain lower the rating.

Where the evidence is stronger and weaker

Knee osteoarthritis is the best-evidenced use. A 2025 meta-analysis graded the evidence as moderate certainty, lowered from high because of varied preparation methods and inadequate blinding in some studies. Diabetic foot ulcer evidence is also typically rated moderate.

Tendinopathy is typically rated low to moderate. A synthesis of 27 randomized trials reported a time pattern: corticosteroid injections did better in the short term, and PRP did better from around three to four months.

Hair restoration is rated low to moderate. Facial rejuvenation is rated low to very low, with small studies and subjective outcome measures.

Known limitations

The main limitation is preparation heterogeneity. Only 33% of studies adequately described the PRP composition, and 17% reported leukocyte content. Two studies labeled PRP may have tested quite different products.

Other limits are short follow-up, usually 3 to 12 months, and difficulty blinding patients and clinicians. Publication bias and inconsistent outcome measures add further uncertainty.

Educational content for healthcare professionals. Not a treatment recommendation. PRP applications are considered off-label.

Platelet-rich plasma (PRP): 0 of 25 lessons finished

All lessons

This guide covers the what and the why.

The how is taught live. The webinar and live training go deeper on:

  • Reading PRP meta-analyses critically
  • Landmark trials by indication
  • PRP compared with hyaluronic acid and corticosteroids
  • Applying evidence grades to case decisions

Common questions.

What condition has the best evidence for PRP?
Knee osteoarthritis is the most extensively studied use, and its evidence has been graded as moderate certainty. Evidence for other uses is generally rated lower or is less consistent.
What does a low GRADE rating mean for PRP?
It means confidence in the estimated effect is limited and the true effect may differ. It reflects uncertainty in the research, not proof that a treatment has no effect.
Why do PRP studies show conflicting results?
Studies use different preparation methods, platelet concentrations, leukocyte content and outcome measures, and many do not report these details. This makes results hard to compare or reproduce.

Sources

  • Gobbi A, Dallo I, Rogers C, et al. Comprehensive summary of the meta-analyses and systematic reviews on platelet-rich plasma therapies for knee osteoarthritis. Mil Med. 2024;189(11-12):e2347-e2357.
  • Bensa G, Murgier J, Godenèche A, et al. PRP injections for the treatment of knee osteoarthritis: The improvement is clinically significant and influenced by platelet concentration: A meta-analysis of randomized controlled trials. Am J Sports Med. 2025;53(1):243-255.
  • Chahla J, Cinque ME, Piuzzi NS, et al. Reporting in clinical studies on platelet-rich plasma therapy among all medical specialties: A systematic review of Level I and II studies. PLoS One. 2021;16(4):e0250007.

Ready for the hands-on detail?

Live on Zoom, Tuesdays at 12:00 PM ET. See how the model works before you commit to anything.